Clarivate Q2 revenue down 5.5% to $587M; net loss $269M on goodwill impairment; reaffirms FY outlook

CLARIVATE PLC

Q2 total revenues $587.3M, down 5.5% YoY; organic revenue -1.5% as subscription +0.7% offset by transactional -15.7%.
Net loss $268.6M ($0.42 diluted EPS) vs $72.0M loss in Q2 2025, driven by $221.7M non-cash goodwill impairment.
Adjusted net income $123.1M ($0.19 diluted EPS) vs $123.3M ($0.18) in Q2 2025; adjusted EBITDA $247.2M vs $261.6M.
First-half 2026 free cash flow $122.9M vs $160.6M prior year; debt reduced by $218.4M including $100M accelerated repayment.
Reaffirms full-year 2026 outlook; previously announced Life Sciences & Healthcare segment divestiture ongoing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.